Biotechnology GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years – GSK (NYSE:GSK) Read more
Biotechnology Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Biotechnology Newly Diagnosed Cervical Cancer Patients – Merck’s Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival – Merck & Co (NYSE:MRK) Read more